Clincosm LogoSign in Get a demo

unknown primary tumors

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PaCIFiC-CUP Classifies Cancer of Unknown Primary

Recruiting
  • Unknown Primary Tumors
  • DNA Methylation
    • Guangzhou, Guangdong, China
      Sun Yat-sen university cancer center
    Nov 20, 2023

    Unknown Primary Tumors, Oropharynx Cancer Trial in Groningen (Detection of lesions using fluorescence molecular imaging)

    Recruiting
    • Unknown Primary Tumors
    • Oropharynx Cancer
    • Detection of lesions using fluorescence molecular imaging
    • Groningen, Netherlands
      University Medical Center Groningen
    Oct 20, 2023

    Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
    • +1 more
    Oct 18, 2022

    Solving Riddles Through Sequencing

    Recruiting
    • Leukemia
    • +5 more
    • Next Generation Sequencing
    • Munich, Germany
      MLL Munich Leukemia Laboratory
    Jan 19, 2022

    NRG1, NRG1 Fusion, Pancreatic Cancer Trial (MCLA-128)

    Available
    • NRG1
    • +11 more
    • (no location specified)
    Jul 21, 2021

    Pulmonary Neuroendocrine Tumor, Pheochromocytoma, Paraganglioma Trial in Houston (177Lu-DOTATOC)

    Recruiting
    • Pulmonary Neuroendocrine Neoplasm
    • +9 more
    • Houston, Texas
      Excel Diagnostics and Nuclear Oncology Center
    Jul 9, 2021

    Unknown Primary Tumors Trial in Italy (nab-paclitaxel, Carboplatin, Gemcitabine)

    Unknown status
    • Unknown Primary Tumors
    • Candiolo, Turin, Italy
    • +9 more
    Sep 1, 2017

    Tumors, Unknown Primary Tumors, Adenocarcinoma Trial in Columbus (Capecitabine, Carboplatin, Paclitaxel)

    Terminated
    Has Results
    • Tumors
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Aug 15, 2016

    Unknown Primary Tumors Trial in Copenhagen (Cisplatin, Paclitaxel, Gemcitabine)

    Withdrawn
    • Unknown Primary Tumors
    • Copenhagen, Denmark
      Rigshospitalet, Dept of Oncology
    May 6, 2015